With the analysis among 123 patents, we discovered top 29 key players by total patent application. IntegraGen SA, F. Hoffmann-La Roche Ltd., Rise Technology, Inc. are dominant in this area. They take 61.79% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Massachusetts, United States
Patent: 16
Neurocrine Biosciences, Inc.
California, United States
Patent: 3
Xenon Pharmaceuticals, Inc.
British Columbia, Canada
Patent: 3
New Jersey, United States
Patent: 2
Takeda Pharmaceutical Co., Ltd.
Massachusetts, United States
Patent: 2
No data, please try another search term
With the analysis among related 5 patents applied in the last 5 years. We discover 6 most active companies in this area. The fast-growing Neurocrine Biosciences, Inc., Becton Dickinson Dispensing UK Ltd., BioXcel Therapeutics, Inc. take 80.00% of patent filing during this period.
Neurocrine Biosciences, Inc.
California, United States
Patent: 2
Becton Dickinson Dispensing UK Ltd.
BERKSHIRE, United Kingdom
Patent: 1
BioXcel Therapeutics, Inc.
Connecticut, United States
Patent: 1
Jiangsu Nhwa Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Sunovion Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
With the analysis among related 5 patents in last 5 years, we discover 5 new entrants. Becton Dickinson Dispensing UK Ltd., BioXcel Therapeutics, Inc., Jiangsu Nhwa Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Becton Dickinson Dispensing UK Ltd.
BERKSHIRE, United Kingdom
Patent: 1
BioXcel Therapeutics, Inc.
Connecticut, United States
Patent: 1
Jiangsu Nhwa Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Sunovion Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
No data, please try another search term